⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tyrosine

Every month we try and update this database with for tyrosine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationNCT00434109
Neuroendocrine ...
Islet Cell Tumo...
Sunitinib malat...
Hepatic Artery ...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesNCT00894894
Solid Tumors
MP-470
amuvatinib (MP-...
18 Years - 70 YearsAstex Pharmaceuticals, Inc.
Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and SunitinibNCT00718562
Gastrointestina...
AMN107
20 Years - Novartis
Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesNCT00894894
Solid Tumors
MP-470
amuvatinib (MP-...
18 Years - 70 YearsAstex Pharmaceuticals, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: